arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Health Catalyst, Inc.

HCAT
$1.51 ▼ -0.09 (-5.63%) at close
Technology ·Services-Computer Programming, Data Processing, Etc. ·USServices-Computer Programming, Data Processing, Etc.
36 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Health Catalyst, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $111.7M
Dividend Yield —
Revenue Growth -12.7% ↘
Op. Margin -51.8% ↗
ROIC -11.3% ↗
FCF / Share $-0.00 ↘
Trailing P/E —
Price / Book 1.1x
FCF Yield —
Debt / Equity 1.52
info Valuation on last close. End-of-day price, Nov 5, 2026.

36-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$70.49M
↓ -12.7% —
Net Income Profit after all expenses
$-40.54M
↑ +1.1% —
Operating Margin Operating profit as % of sales
-51.8%
↑ +65.6% 5th
FCF / Share Free cash flow per share
$-0.00
↓ -100.4% —
Long-Term Debt Long-term obligations
$153.48M
— +0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
11
Returns ↓
12
Financial Health ↑
38
Cash Quality ↓
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 36 quarters